– Findings from a retrospective analysis suggest that patients with baseline acute-on-chronic liver failure (ACLF) grade ≤2 treated with TERLIVAZ ® plus albumin had a higher incidence of HRS reversal ...
Financing from RA Capital Management, Venrock and Vivo Capital will enable the biopharmaceutical company to advance OCE-205 for treatment of hepatorenal syndrome Phase 2 clinical trial to initiate in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback